News: Dexa Group

The President of the Republic of Indonesia (RI) Mr. Joko Widodo appreciated and encouraged the use of Indonesia Indigenous Modern Medicine (OMAI) in the National Health Insurance (JKN). This was conveyed during a visit to the Dexa Group booth with the theme OMAI Fitofarmaka at the Business Matching Exhibition for…

The Indonesian Pharmaceutical Companies Association (GP Farmasi) held an interactive dialogue entitled "Safe Medicinal Syrups for Children". It was revealed that the requirement for safe syrup preparations is in accordance with the provisions of the Food and Drug Administration (BPOM). "BPOM in conducting evaluations, in issuing permits, many standards are…

Dexa Group Wins Public Relations Indonesia Awards 2023 After going through a gradual judging process and presenting proposals, Dexa Group's Corporate Communications is considered to have a significant and positive impact on Public Relations (PR) performance throughout 2022. For this achievement, Dexa Group has won the highest award at the…

Dexa Group was awarded The Best Indonesia Public Relations in the Health Sector by the Indonesia Corporate Public Relation Awards (IPRA) 2023. Dexa Group has won the IPRA Award for the fifth time since 2018. With the theme “Winning Economic Growth Through Consistent Collaboration", IPRA 2023 is being held to…

Domestic pharmaceutical industry with international standard, Dexa Group participated in Expo of Food and Drug Life Cycle Product Supervision held by The Indonesian National Agency of Drug and Food Control (Badan POM). This event is an educational event from Badan POM as the regulator and the pharmaceutical and food industry…

For his leadership that has allowed the company to adapt successfully, make breakthroughs, and continue to make developments to provide a positive stimulant to the economy in Indonesia, Dexa Group CEO Mr. Ferry Soetikno was awarded the Indonesia Most Acclaimed CEO 2022 in the pharmaceutical category from WartaEkonomi.co. id. Indonesia…

As a pioneer in the implementation of research for the Indonesia Indigenous Modern Medicine (OMAI) products certified by the Halal Product Assurance System, Dexa Group has achieved the Indonesia Halal Industry Award (IHYA) 2022 for the Best Halal Innovation category. The award held by the Ministry of Industry of the…

Dr. Raymond Rubianto Tjandrawinata, a leading figure in Indonesia Indigenous Modern Medicine (OMAI), was awarded the honorary title of Adjunct Professor in Pharmaceutical Biotechnology by the Indonesian Catholic University (Unika) Atma Jaya Jakarta. Dr. Raymond Rubianto Tjandrawinata has demonstrated a scientific discovery and contribution to the advancement of pharmaceutical biotechnology,…

Mr. Ferry Soetikno, the leader of the Dexa Group, served as a speaker during the Sanata Dharma University Yogyakarta Public Lecture. During his guest lecture, Mr. Ferry covered two subjects for hundreds of University of Sanata Dharma students and graduates: the introduction of Dexa Medica and the independence of pharmaceuticals…

Dexa Group took part in the 58th National Health Day Exhibition's Opening Ceremony on Thursday, November 3, 2022, at the Indonesia Convention Exhibition (ICE) BSD, Tangerang. With the theme Indonesian Pharmacy Resilience and Independence, Dexa Group set up a booth at the event. The occasion was attended by the Minister…